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Introduction: Humans are intentionally exposed to gold nanoparticles (AuNPs) where they are
used in variety of biomedical applications as imaging and drug delivery agents as well as
diagnostic and therapeutic agents currently in clinic and in a variety of upcoming clinical trials.
Consequently, it is critical that we gain a better understanding of how physiochemical properties
such as size, shape, and surface chemistry drive cellular uptake and AuNP toxicity in vivo.
Understanding and being able to manipulate these physiochemical properties will allow for the
production of safer and more efficacious use of AuNPs in biomedical applications.
Methods and Materials: Here, AuNPs of three sizes, 5 nm, 10 nm, and 20 nm, were
coated with a lipid bilayer composed of sodium oleate, hydrogenated phosphatidylcholine,
and hexanethiol. To understand how the physical features of AuNPs influence uptake through
cellular membranes, sum frequency generation (SFG) was utilized to assess the interactions
of the AuNPs with a biomimetic lipid monolayer composed of a deuterated phospholipid
1.2-dipalmitoyl-d62-sn-glycero-3-phosphocholine (dDPPC).
Results and Discussion: SFGmeasurements showed that 5 nm and 10 nm AuNPs are able to
phase into the lipid monolayer with very little energetic cost, whereas, the 20 nmAuNPs warped
the membrane conforming it to the curvature of hybrid lipid-coated AuNPs. Toxicity of the
AuNPs were assessed in vivo to determine howAuNP curvature and uptake influence cell health.
In contrast, in vivo toxicity tested in embryonic zebrafish showed rapid toxicity of the 5 nm
AuNPs, with significant 24 hpf mortality occurring at concentrations ≥20 mg/L, whereas the 10
nm and 20 nm AuNPs showed no significant mortality throughout the five-day experiment.
Conclusion: By combining information from membrane models using SFG spectroscopy
with in vivo toxicity studies, a better mechanistic understanding of how nanoparticles (NPs)
interact with membranes is developed to understand how the physiochemical features of
AuNPs drive nanoparticle–membrane interactions, cellular uptake, and toxicity.
Keywords: gold nanoparticle, vibrational spectroscopy, nanoparticle–biological interactions,
hybrid lipid-coated nanoparticle, toxicity, size-dependent interaction, zebrafish
Introduction
Nanoparticles (NPs) have many novel applications in medicine, one of which is the
development of nanoparticle-based therapeutics and imaging agents.1 Incorporating
drugs into NP platforms that serve as drug delivery vehicles provides a variety of
benefits: improved solubility and clinical efficacy as well as decreased degradation,
physiologic clearance rates, systemic toxicity.2 However, these benefits do not come
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without their costs. The approval of the first FDA-
approved nanotherapeutic Doxil® in 1995 was followed
by more than 50 other nanotherapeutics for use in clinical
trials.3 Most nanoparticle-based delivery systems are based
on liposomal or polymer formulations; however, metal-
based colloidal systems such as gold nanoparticles
(AuNPs) are also being investigated for use in cancer
therapy.4 For example, AuNPs have also been heavily
researched for use in plasmonic photothermal therapy
(PPTT),4–9 tumor-targeted drug delivery,4,10–12 and uti-
lized to fight multi-drug resistant cancers.13–16
Consequently, their growing use in clinical trials, cancer
therapies, and other biomedical applications have brought
to light a need to better understanding of interactions
between nanomaterials and biological systems.17 That is,
there is a critical need to better understand how the phy-
siochemical properties of NPs, such as size, shape, surface
area, charge, and surface chemistry drive cellular uptake
and toxicity. An improved understanding of nanoparticle-
biological interactions (NBIs) and toxicity are critical if
we are design of safer and more efficacious AuNP-based
platforms that can be used for imaging and drug delivery.
Although the core of AuNPs is considered to be non-
toxic and biologically inert,18 many studies show that
changes to the size, shape, surface charge and coating of
AuNPs can elicit different toxic responses. For example,
changing the surface charge on AuNPs results in differen-
tial sub-organ distribution,19 pharmacokinetics, excretion,
and tumor uptake in mice.20 The coating on the surface of
AuNPs provides many benefits such as allowing for the
delivery of small molecules to specific sites in the body
and plays a major role in the biocompatibility of AuNPs
for use in biomedical applications. For example, natural
ligands such as glutathione and modified peptide-
derivatives, when coated onto AuNPs, were found to be
biocompatible in zebrafish compared to those that had
impurities.21 More recently, poly-ethylene-glycol (PEG)-
coated AuNPs showed lower hepatotoxicity in rats when
compared to uncoated AuNPs.22 In addition to surface
charge and coating, the size and shape of the AuNPs also
critically affect efficacy and toxicity. Studies have shown
that smaller gold nanospheres have increased cellular
uptake, compared to their larger AuNPs with the same
surface coating.23–25 This size-dependent biodistribution
and excretion of AuNPs has been observed in mice
exposed to repeated doses of AuNPs and is often attributed
to their differential mechanisms of cellular uptake.26
Mironava et al showed that 45 nm AuNPs penetrate cells
via clathrin-mediated endocytosis, while the smaller 13 nm
AuNPs entered cells via phagocytosis.27 While these stu-
dies assess the size-dependent nature of AuNP toxicity,
they do so independently of the studies that assess size-
dependent cellular uptake making it difficult to understand
the connection between the two as various properties of
AuNPs vary from study-to-study. In order to adequately
assess and correlate the size-dependent nature of AuNP
uptake and toxicity, a single study must be performed,
assessing the interactions of the AuNPs at various levels
of biological complexity ranging from cellular to
organism.
While in vitro and in vivo studies of NP uptake have
provided a wealth of knowledge regarding the mechanism
and efficiency of NP uptake, distribution, and toxicity, con-
sensus regarding dosimetry based on NP size is still lacking
as these studies have not agreed on which is more important
size, shape, or surface area.28–31 There is a critical need for
a systematic study to correlate the effects of the physiochem-
ical features of NPs with cell membrane response if we are to
design better NPs with minimal human health impact for
biomedical applications. One approach to a systematic
study is through the use of well-studied biomimetic lipid
monolayers that have been employed to assess the interac-
tions of biomolecules or NPs with a lipid monolayer.32–41
Structural changes in the biomimetic lipid monolayer are
monitored by sum-frequency generation (SFG) vibrational
spectroscopy, a second-order nonlinear optical technique.
SFG is capable of detecting the adsorption and orientation
of biomolecules at sub-micromolar concentrations.42–46
Through the utilization of a fixed visible laser, pulsed in
temporal and special synchronicity with a tunable-infrared
laser, SFG can measure sum-frequency photons. Sum-
frequency photons generated by nonlinear optical frequency
mixing carry a vibrational spectrum sensitive to molecular
order. SFG is capable of directly identifying interactions
between NPs and model cell membranes with molecular
resolution.33–41,47–55 Using SFG to directly probe the order
of the acyl chains of the lipid monolayer allows for direct
observation of how the AuNPs change the packing and
ordering of the lipids of the model cell membrane to provide
fundamental understanding of how NPs interact with cells to
drive uptake and if this correlated with toxicity.
Here, our objective is to evaluate the in vivo effects of
various sized AuNPs (5 nm, 10 nm, and 20 nm core size) and
establish relationships between in vivo toxicity and cellular
uptake through interactions of AuNPs with a biomimetic
model cell membrane. For these studies, AuNPs were coated
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with robust and tightly packed lipid bilayer composed of
sodium oleate (SOA), hydrogenated phosphatidylcholine
(hPC), and hexanethiol (HT). We hypothesized that the
smaller, 5 nm, AuNPs would cause increased toxicity as
their smaller size will allow for more efficient integration
into cellular membranes, and thus uptake into cells at a lower
energetic cost than their larger 10 nm and 20 nm counter-
parts. The toxicity of the AuNPs were assessed in vivo. For
the in vivo toxicity testing, embryonic zebrafish (Danio
rerio) was used as a model organism because of their rapid
development and ease of use in nanotoxicology studies.56–61
Embryonic zebrafish have very similar molecular signaling
processes, cell structure, anatomy, and physiology as other
higher-order vertebrates, including humans.62–65 Hence,
embryonic zebrafish allow for observation of whole organ-
ism toxicity in a model that is relevant to human health, as
humans are the ultimate target of many AuNP applications.
Combining in vivo toxicity studies with complementation
studies using SFG spectroscopy and model membranes we
are able to elucidate our gap in knowledge in understanding
of how NP size and curvature influence interactions with
membranes to drive uptake and toxicity.
Methods and Materials
Reagents
Aqueous solutions of 5, 10, and 20 nm gold citrate-capped
NPs were purchased from Ted Pella, characterization infor-
mation has been provided in Table S1. Chloroform (CHCl3)
and L-α-phosphatidylcholine-hydrogenated soy (HPC) were
purchased from Sigma-Aldrich while 1.2-dipalmitoyl-d62-sn
-glycero-3-phosphocholine (dDPPC) was from Avanti Polar
Lipids Inc, Alabaster, AL, USA. Ninety-five percent 1-hex-
anethiol (HT) and sodium oleate were purchased from
Sigma-Aldrich. Tween-20 was purchased from Sigma-
Aldrich. Sodium phosphate monobasic monohydrate,
sodium phosphate dibasic heptahydrate, sodium chloride,
and hydrochloric acid were from BDH Chemicals. Sodium
bicarbonate was from J.T. Baker. Nanopure water was from
a Milli-Q ultra-pure system. Potassium cyanide (KCN) was
from Mallinckrodt. All reagents were used as received.
Physical Measurements
UV-Vis spectra were recorded in ultra-pure water using
a USB4000 UV−visible-NIR spectrophotometer (Ocean
Optics, Dunedin, FL, USA) with a 1.0 cm path length
quartz cell.
Preparation of Hybrid Lipid-Coated
Spherical AuNP (Diameter = 5, 10, or 20
Nm)
SOA (9.1 µL for 5 nm, 2.2 µL for 10 nm, and 0.514 µL for
20 nm AuNPs of a 9.3 mM solution in H2O) was added to
1 mL of AuNPs (0.8 optical density (O.D.) for 5 nm
(lambda max at 520 nm), 0.8 O.D. for 10 nm (lambda
max at 520 nm), and 1.08 O.D. for 20 nm (lambda max at
524 nm) in H2O) and stirred for 20 min. This was followed
by the addition of preformed HPC liposomes (87 µL for 5
nm, 20 µL for 10 nm, and 8.7 µL for 20 nm of a 0.54 mM
solution in sodium phosphate buffer pH 8) and incubation
for 40 min. The HPC liposomes were prepared using a well-
established method where a solution of HPC (50 µL of
a 21.6 mM solution in CHCl3) was evaporated under
a stream of N2 as a thin film and placed under vacuum of
12 h to remove trace organic solvents prior to resuspension
in 2 mL of 10 mM phosphate buffer at pH 8.0 for a final
concentration of 0.54 mM (Supplemental Materials). The
solution was shaken vigorously to re-suspend the lipids and
sonicated for 90 min until the cloudy solution was transpar-
ent. Finally, HT (4.2 µL for 5 nm, 1 µL for 10 nm, and 0.65
µL for 20 nm of a 10 mM solution in ethanol) was then
added to the AuNP-SOA-HPC solution and stirred for an
additional 30 min. Before purification by ultracentrifuga-
tion, each 1 mL solution of Au-SOA-HPC-HT was stirred
with Tween-20 (47.2 µL for 5 nm, 10.1 µL for 10 nm, and
4.3 µL for 20 nm of a 10 mM solution in H2O) for 30 min to
break up liposome-free NPs for removal. Purification of
Au-SOA-HPC-HT was performed by ultracentrifugation
with a Thermo Scientific Sorvall ST 40R at 4700 rpm
using GE Healthcare ultracentrifugal concentrators with
a PES membrane (Vivaspin 20, MWCO = 10 kDa) in a 10
mM sodium phosphate buffer at pH 8.0 (4 min x 10 rounds).
Stability and Cyanide Etch Studies
ForNaCl studies, 1mL solutions ofAu-SOA-HPC-HT (X= 5,
10, or 20 nm) with an O.D. of 0.8 (or concentrations 4.7 x 1013
nps/mL= 5 nm, 4.7 x 1012 nps/mL=10 nm, and 4.7 x 1011 nps/
mL = 20 nm) were exposed to 5 M NaCl (aq) to yield final
concentrations of 50mM, 150mM, and 200mMNaCl. For the
pH study, the pH was adjusted to 2 or 5 by the addition of 2
M HCl (aq). For freshwater (FW) studies, a solution of FWat
pH 7.4 was prepared by adding 0.26-g aquarium salt and 0.01-
g sodium bicarbonate to 1 L DI water. A 1 mL aliquot of the
FW solution was combined with 1 mL of Au-SOA-HPC-HT
(5, 10, or 20 nm at O.D. 0.8) for a final O.D. of 0.4. To
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determine if the AuNPs were completely covered by a hybrid
lipidmembrane coating, Au-SOA-HPC-HTwas exposed to 20
µL of 307 mM of KCN for a final concentration of 6.14 mM
KCN for 1 hr. The UV-Vis spectra were taken for all samples
described here where the percent change in the λmax and O.
D. was monitored to assess NP stability.
SFG Vibrational Spectroscopy and Lipid
Monolayer Formation
For the SFG setup, an EKSPLA Nd:YAG laser, operating at
50 Hz, was used to generate both a fixed visible (532 nm−1)
and tunable IR beam (1000–4000 cm−1). Beams were
focused to approximately a 1mm diameter spot at the inter-
face. The visible and IR beams overlapped in space and time
to produce SFG photons. Spectra were collected in 2 cm−1
steps with 200 acquisitions per step. Three consecutive spec-
tra were collected and summed before and after the NPs
interacted with the lipid monolayer. SFG spectra were col-
lected in the ssp polarization combination (s-polarized SFG,
s-polarized visible, p-polarized IR) in the C-D vibrational
region (1900–2250 cm−1) and the C-H vibrational region
(2800–3000 cm−1). The SFG spectra were normalized by
dividing the collected signal at each wavelength by the
visible and infrared beam intensities. The SFG spectra were
fit with Equation 1.35,66,67
χ 2ð Þ ωð Þ ¼ χ 2ð ÞNR þ∑q
Aq
ω ωq þ iΓq (1)
Where Aq,Γq and ωq are the amplitude, full-width half max
and frequency of the qth vibrational mode, respectively.
χ 2ð Þand χ 2ð ÞNRare the second-order nonlinear susceptibility
tensor and the nonresonant background, respectively.
A lipid monolayer comprised deuterated phospholipids
was formed at the air/water interface in a polytetrafluoroethy-
lene (PTFE) trough containing approximately 10 mL of MQ
H2O. The monolayer consisted of a deuterated 1.2-dipalmi-
toyl-d62-sn-glycero-3-phosphocholine (dDPPC) (Figure S1).
The lipids were dissolved in CHCl3 at a concentration of
0.125 mg/mL and added dropwise to the surface of the H2
O layer using a Hamilton microsyringe in 5 µL increments.
The dDPPC contains isotopically labeled acyl chains to dis-
tinguish the vibrational modes from the lipid monolayer and
NPs. After letting the CHCl3 evaporate, approximately 15
min, spectra were collected to ensure the desired packing of
lipids at the air/water interface. Two packing densities of lipids
were used for the experiment, according to Ingolfsson et al the
average area per lipid on the outer leaflet of a cell membrane is
between 51 and 55 Å2 per molecule.68 This range is on the
border of what is described by Roke et al as the liquid con-
densed (LC) and the mixed liquid condensed and liquid-
expanded (LC+LE) region.69 The LC region exists beneath
areas of 47 Å2 per molecule, while the LC+LE region exists
between areas of 50–80 Å2 per molecule. To achieve a lipid
monolayer within the range of what is observed in a cellular
membrane we chose to use two different packing densities to
achieve the LC and LC+LE environments for the AuNPs to
interact. This was followed by the injection of Au-SOA-HPC-
HT beneath the air/water interface for a final concentration of
20 mg/L. Following Au-SOA-HPC-HT injection,35 the NPs
were allowed to equilibrate for 4 hrs with the lipids to ensure
homogeneity in the trough.
Toxicity Studies
In vivo Embryonic Zebrafish Toxicity
Adult zebrafish (Danio rerio) were maintained at Oregon
State University’s Sinnhuber Aquatic Research Laboratory
(SARL) in a water flow-through system under standard
laboratory conditions: constant temperature of 28°C under
a 14:10 hour light-dark cycle.70 Embryos were collected
and staged from group spawns of wild-type tropical 5D
zebrafish. Staging is important to ensure that all embryos
are at the same developmental stage at the start of each
experiment.71 Embryos were enzymatically dechorionated
at 6 hrs post fertilization (hpf) using pronase (Sigma-
Aldrich, St. Louis, MO, USA) following the procedure
of Usenko et al72 Removal of the chorion is critical as
the chorion has been shown to protect the embryo from
exposure, serving as a physical barrier and sink for nano-
materials and other chemicals.73,74 At 8 hpf, the dechor-
ionated embryos were individually exposed to 200 μL of
AuNP suspensions with concentrations of 2.5 mg/L, 5 mg/
L, 10 mg/L, 20 mg/L, 30 mg/L, 40 mg/L, and 50 mg/L in
fish water in clear flat-bottom 96-well plates (n = 24 per
concentration). Plates were incubated at 26.9°C under a -
14:10 hour light-dark cycle. At 24 hpf, embryos were
evaluated for mortality, developmental progression, noto-
chord malformations, and presence of spontaneous move-
ment. Spontaneous movement a behavioral end point
described by Kimmel et al as “rhythmic bouts of
swimming.”71 All three 24 hpf end points occurred in
a significant number of fish exposed to the AuNPs in this
study. At 120 hpf, embryos were evaluated for a second
time for mortality along with a suite of other physiologi-
cal, behavioral, and morphological endpoints. In this
study, there were no significant sublethal malformations
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observed at 120 hpf. All experiments were performed in
compliance with national care and use guidelines and
approved by the Institutional Animal Care and Use
Committee (IACUC) at Oregon State University, ACUP
#5114.
Statistical Analyses
Statistical analyses were performed using Sigma Plot 13.0
(Systat Software, San Jose, CA, USA). Fisher’s exact test
was used to compare specific developmental endpoints
between treatment and controls in the embryonic zebrafish
assay. Analysis of variance (ANOVA) was used to evalu-
ate differences among treatment groups across equivalent
concentrations. Differences were considered statistically
significant at p ≤ 0.05 for all analyses.
Results and Discussion
Preparation and Characterization of
Hybrid Lipid-Coated AuNPs
For this study, hybrid lipid-coated AuNPs were prepared
using a previous strategy where AuNPs were coated
with SOA and pre-formed liposomes comprised
L-a-phosphatidylcholine that are anchored to the AuNP sur-
face with a long-chain hydrophobic thiol.75–77 AuNP colloids
with diameters of 5, 10, and 20 nm were coated with hydro-
gen phosphatidylcholine (HPC), which has two saturated
hydrocarbon tails. These diameters were chosen because to
represent a range of sizes with unique radius of curvature that
can be systematically studied to evaluate their uptake how
size and radius of curvature affect interactions with mem-
brane model systems, uptake into cells, and toxicity. The
AuNP core, surface chemistry, and charge was kept constant.
To ensure that the HPC membrane was completely
covering the NP surface in a tight packing arrangement,
a cyanide (CN−) etch test was performed. CN− is a well-
known etchant of gold and oxidizes Au0 to AuI.76,78 Upon
exposure to CN−, the UV-Vis spectra of the hybrid lipid-
coated AuNPs after 1 h showed no change in the localized
surface plasmon resonance (LSPR) of the AuNPs
(Figure 1) indicating that there is no “bare” patches of
gold surface and that the HPC lipid membrane is in a tight
packing arrangement that CN− is unable to penetrate
through the lipid bilayer for CN− to etch. Resistance to
CN− etch was observed for the 5, 10, and 20 nm and is
consistent with previous studies (Figure S2).75,76
Stability of Hybrid Lipid-Coated AuNPs
Since the ultimate target of hybrid lipid-coated AuNPs is for
in vitro cellular studies and in vivo embryonic zebrafish
studies as well as their potential use in biomedical applica-
tions in vivo, their stability in biological media is important.
Therefore, stability studies at a range of physiological pH and
ionic strengths with the 5, 10, and 20 nm Au-SOA-HPC-HT
were performed. In order to standardize our results for com-
parison of all three sizes, an O.D. of 0.8 was used for all
AuNPs. This equated to Au-SOA-HPC-HTconcentrations of
4.7 x 1013 nps/mL = 5 nm, 4.7 x 1012 nps/mL = 10 nm, and
4.7 x 1011 nps/mL = 20 nm. To evaluate the effect of
physiological salt concentrations on the stability of the Au-
SOA-HPC-HT, samples were exposed to varying NaCl con-
centrations ranging from 50 mM to 200 mM and the UV-Vis
spectra taken after 1 and 24 h of incubation. The percent
change in the O.D. and λmax was monitored to assess NP
aggregation and dipole-dipole coupling.79,80 For all Au-SOA
-HPC-HT diameters under varying salt concentrations,
the percent change in λmax for all hybrid Au-SOA-HPC-HT
was 2.5% or less. More distinct differences were observed
with change in O.D. and were used as an indicator of NP
stability. Minimal change in O.D. is observed with the 5 nm
Au-SOA-HPC-HT upon exposure to the 50–200 mM NaCl
concentrations (Figure 2A). The 10 nm Au-SOA-HPC-HT
exhibited a 14% decrease in O.D. at 1 hr (Figure 2A) and
declined further (24%) after 24 hrs (Figure S3) upon incuba-
tion with 200 mM NaCl. A much more significant decrease
in the O.D. is observed for the 20 nm Au-SOA-HPC-HT in
the presence of 50–200 mM NaCl within 1 hr (Figure 2A)
and remained that way over 24 h (Figure S3). Based on these
Figure 1 Representative UV-Vis spectra of 5 nm diameter Au-SOA-HPC-HT i)
before and ii) after the addition of 6.14 mM KCN for 1 h in H2O.
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changes in O.D. the 5 and 10 nmAu-SOA-HPC-HTare most
stable compared to the 20 nm; however, the amount of salt
present relative to the exposed number of NPs present in the
solution must be taken into account. That is, the number of 20
nm NPs per mL (4.7 x 1011 nps/mL) is less than that of the 5
nm (4.7 x 1012 nps/mL) and 10 nm (4.7 x 1011 nps/mL) under
the same salt exposure concentrations. In addition, the total
number of lipids present in solution is based on the number of
nanoparticles present in solution, that aides in increasing
solubility and decreasing aggregation, is less for the 20 nm
< 10 nm < 5 nm. Therefore, 20 nm Au-SOA-HPC-HT due
are exposed to a much higher amount of Cl− in a 1 mL
solution leading more NP-NP interactions than the 5 and 10
nm NPs. This is confirmed by adjusting the 20 nm Au-SOA-
HPC-HT concentrations to have the same number of NPs at
the 10 nm sample at 8.2 x 1011 nps/mL with an O.D. of 1.4,
the stability of the 20 nm improved greatly compared to
lower concentrations upon exposure to salt for 1 h and 24 h
(Figure S4). While it is possible that instability can occur
from lipid dissociation from the AuNP surface in high salt
concentrations, prior studies investigating the robustness of
the hybrid lipid-coated AuNPs and silver nanoparticles
(AgNPs) confirm that the lipids are arranged in a very tightly
packed fashion that is impermeable.76 UV-Vis and TEM
studies that hybrid lipid-coated AuNPs and AgNPs (that is
more susceptible to oxidation compared to AuNPs) in the
presence of membrane-disrupting surfactants such as
TWEEN®20 or Triton-X100 and KCN show that both
AuNPs and AgNPs are stable to CN− etch.76 This confirms
that in the presence of membrane-disrupting surfactants the
nanomaterials remain stable and that the lipids do not come
off the surface. In addition, upon exposure of citrate-capped
AgNPs and hybrid lipid-coated AgNPs to 50 mM NaCl and
have shown that when the AgNP surface is exposed to AgNP
the Cl− induces surface oxidation to citrate-capped AgNPs
while no surface oxidation is observed with hybrid lipid-
coated AgNPs as confirm by UV-Vis and ICP-MSmeasuring
Ag+ ion release.81 The hybrid lipid-coated AuNP and AgNPs
are stable in the presence of CN− and Cl− for months as
confirmed by ICP-MS.76,81 Lastly, since in this study, the Au-
SOA-HPC-HTNPs will be exposed to zebrafish embryos the
stability was also evaluated and monitored in fish water
(FW). Au-SOA-HPC-HT mixed with the FW in a 1:1 ratio
are found to be relatively stable in the FWmedia as indicated
by the minimal change in the O.D. (Figure S5). This is as
expected since the fish water solution is at a neutral pH and
its salinity is minimal. Overall, hybrid lipid-coated AuNPs
are stable under physiological concentrations of salts and
in FW.
It is well known that nanomaterials are taken up into
cells into lysosomal compartments where the pH is 5 and
cellular level interactions can induce changes in the phy-
sicochemical properties of the NPs, changes physiological
structure of the cell and its behavior, and toxicity.82–85 To
evaluate the stability of the AuNPs under varying pH
conditions, the acidity was adjusted with 2 M HCl (aq)
and the change in O.D. was monitored by UV-Vis spectro-
scopy. All diameters of Au-SOA-HPC-HT are stable at pH
8.0, as was expected, since the HPC head group remains in
its zwitterionic form suspending the AuNPs in aqueous
solution (data not shown). Reducing the pH to 5 did not
have a significant effect on the stability of the 5 nm hybrid
NPs. However, after 1 h, at pH 5 and pH 2, the 10 nm and
20 nm HPC-AuNPs aggregated and there is a lost in
Figure 2 Percent change in O.D. of hybrid lipid capped Au-SOA-HPC-HT in 10 mM sodium phosphate buffer pH 8.0 1 h after (A) exposure to 50 mM, 150 mM, or 200 mM
NaCl (aq) and (B) adjustment of pH to 2 and 5 with 2 M HCl. Data mean ± SE reported for n = 3.
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stability as evidenced by the significant decrease in O.D.
(Figure 2B). A much higher ratio of H+ ions to available
lipids on the 10 and 20 nm Au-SOA-HPC-HT is present
and protonates the PC headgroups to neutral charge to
cause aggregation. This loss in stability is much more
noticeable at pH 2 where 40% and 88% decrease in O.
D. is observed for 10 and 20 nm Au-SOA-HPC-HT,
respectively. Regardless of aggregation, the hybrid lipid
membrane anchored to the AuNPs remains intact to shield
the surface of the AuNPs as no shift in the LSPR band is
observed. These studies help to elucidate how the behavior
in their media might influence cellular uptake and toxicity.
Lipid Monolayer Interactions
Insight into how a cell membrane lipid interface responds
to the presence of AuNPs of various sizes can be gained
by collecting SFG spectra at a NP-lipid interface. SFG has
been used to study how DNA,86 proteins,35 and NPs54
manipulate lipid membranes. Previous investigations of
NP-lipid interactions indicate that NP size and coating
dictate the mechanism by which the particles transport
themselves through a lipid interface. Recent characteriza-
tions of interactions between a lipid bilayer and spherical
citrate-coated AuNPs of different sizes demonstrate with
SFG that for all sizes flip-flopping of the lipids that made
up the bilayer always occurred.87 Where the lipid “flip-
flop” describes a process undertaken by the cell for
a variety of processes including apoptosis, viral infection,
and membrane growth. The flip-flop observed in SFG
experiments induced by NPs at a lipid interface represents
the penetration of the particle through a cell membrane.88
While an additional investigation using SFG showed that
AuNPs with a specific charge or coating can induce lipid
conformation around the particle.55 The idea of a lipid
membrane wrapping around a particle is supported by
other work examining NP uptake by cells.89,90 This body
of work implies that factors such as size and coating,
directly influence particle–lipid interactions.
To identify how the structure of the lipid monolayer is
affected by the presence of Au-SOA-HPC-HT, SFG spectra
were taken before and after the AuNPs were injected under
a model lipid monolayer. Similar experimental setups have
been described elsewhere.35,87,91 All the spectra contain
features related to C-D vibrational modes within the deut-
erated lipids (Figures 3 and 4).35,92,93 Assignments and fits
for each spectral feature can be found in (Table S2–4). The
deuterated dDPPC allows us to isolate the carbon species
within the lipid monolayer from the non-deuterated DPPC
on the NPs. In this study changes in the peaks related to the
symmetric CD2 stretch at 2100 cm
−1 and asymmetric CD2
stretches present at 2202 cm−1 provide insight into the
structure of lipid tails at the air/water interface.
Specifically, changes in the CD2 peak height indicate
a shift in the packing of the lipid monolayer. Therefore,
variations of the intensities of the CD2 vibrational modes
were measured before and after NP injection. For
a monolayer in a LC state, the acyl chains of the lipid will
be packed tightly resulting in an all-trans conformation. In
this case, signal generated from the CD2 vibrational modes,
will cancel each other out, leading to no observable SFG
signal. Consequently, with a less ordered monolayer, the
acyl chains no longer pack as tightly and are free to move,
leading to gauche defects; therefore, the intensity of the
CD2 peak within the resulting SFG spectrum will become
more prominent. Changes in the CD2 peak height after NP
injection gives insight into the mechanism by which the
AuNPs interact at the lipid interface.
Interactions between the 5 and 10 nmAuNPs and dDPPC
lipids show the same response, no matter the initial packing
density (LC and LC+LE states) (Figure 3). Each of the lipid
monolayers are packed together more tightly after AuNP
injection. This is confirmed by the intensity of the CD2
peaks in the SFG spectra (Figure 3). In the case of 5 nm
and 10 nm AuNPs there is an observed reduction in the CD2
peak at 2100 cm−1 following the injection of AuNPs
(Figure 3A and B). The change shows that the lipids in the
monolayer are being pushed together because the CD2 peak
Figure 3 SFG spectra in the CD region of (A) LC+LE monolayer and (B) a LC
monolayer before and after the injection of 5 nm AuNPs. The black squares show
the lipid monolayer before NPs were injected. The blue circles show the lipid
monolayer and NP interaction after 4 h. The symmetric CD3 stretch is at
2075 cm−1 with the symmetric CD2 stretch at 2100 cm
−1. The symmetric CD2
peak disappears after NP injection for both LC (A) and LC+LE (B) monolayers
indicating the NPs pushed the lipid tails into a trans conformation.
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has disappeared. In this study, the binding of 5 and 10 nm
AuNPs to the lipids, in both the LC and LC+LE states,
adopted an increasingly trans conformation shown in the
reduction of the CD2 peak at 2100 cm
−1 (Figure 3). When
lipids adopt a greater degree of trans conformation, this
indicates a compression of the lipid monolayer.38 This obser-
vation implies that the NP inserts itself into the lipid mono-
layer. Effectively pushing the lipids closer together similar to
the “snorkel” effect observed in Monte Carlo simulations
assessing free energy changes of lipid penetration.94 The
same simulation shows the lowest energy barrier for the
“snorkeling” of a spherical AuNPs with a diameter slightly
below 5 nm, in agreement with observed SFG spectra. In
contrast, the 20 nm AuNPs CD2 peak either remained or
disappeared after AuNP injection (Figure 4). Compared to
the smaller sized particles, the 20 nm AuNPs exhibit
a different interaction with the lipid monolayers.
Additionally, the lipid response to the 20 nm AuNPs is
dependent on the lipid packing density of the monolayer.
For the LC+LE monolayer, there is a lack of CD2 or CD3 at
2100 cm−1 and 2075 cm−1 peaks, respectively, after NP
injection shown in (Figure 4A). This lack of SFG signal in
the less dense layer, after AuNP injection, at these vibrational
modes is likely due to the collapse of the lipid monolayer,
producing a random ordering of the lipids within the mono-
layer. However, this is not the case for the denser lipid
monolayer, where the CD3 and CD2 peaks at 2075 cm
−1
and 2100 cm−1 are still present within SFG spectra collected
as the 20 nm AuNPs interact with the LC monolayer
(Figure 4B). Thereby, implying that the LC monolayer
remains intact in the presence of the 20 nm AuNPs. The
CH vibrational modes provide more information on the lipid
response to the AuNPs because only the tails of the lipid are
deuterated.
The CH region is used to probe stretches on the head
group of the lipids at the AuNP surface (Figure S1). The
head group of the lipids are not deuterated, the CD
vibrational modes come from the tails only. The SFG
spectra showed two distinct modes visible near 2913
and 2963 cm−1 assigned to the asymmetric stretches of
the methyl and methylene groups of the lipids and other
ligands on the AuNP surface (Figures 5 and 6).86,92,93,95,96
A similar response has also been observed by Ma and
Allen et al with the same lipids.38 Symmetric stretches
were present with comparably low signals for the lipid
monolayer and AuNPs.38 With only asymmetric stretches
being noticeable, it is likely that the headgroup of the
lipids, the source of the CH signal for dDPPC, lie closer
to the surface than the surface normal.97,98 This is due to
the stretches that can be observed in the ssp polarization
combination. If the plane of symmetry for the methyl
group lies parallel to the surface, only the asymmetric
stretches will be observed. It is important to also note that
observation of the head group orientation is not depen-
dent on the degree of packing density for the lipid
monolayer.38 This is in contrast to lipid tails, whose
orientation becomes more uniform with increasing pack-
ing densities.
Analysis of the SFG spectra shows that the 5 and 10 nm
AuNPs push their way into the LC+LEmonolayer, where the
20 nm AuNPs are large enough collapse it. The CH spectra
confirm the presence of AuNPs at the interface and that this
collapse only occurs because of the AuNPs. Of the three
AuNPs used in this study, the 20 nm AuNP was the only
one dependent on the initial state of the lipid monolayer for
its interaction. It either binds to the monolayer, inducing
curvature, keeping it intact or sufficiently disrupts the mono-
layer to cause disorder. While the high curvature 5 and 10 nm
NPs induce the same lipid response, pushing the lipids that
make up the monolayer closer together, implying that both
“snorkel” through the layer.
The collection of SFG spectra indicates that size is an
important factor for NP penetration as evidenced by the
different responses observed when comparing the 5 and 10
Figure 4 Representative SFG spectra in the CD region of (A) with a LC+LE
monolayer and (B) with a LC monolayer. The black squares show the lipid mono-
layer before 20 nm NPs were injected. The blue circles show the lipid monolayer
and NP interaction after four hours. The symmetric CD3 stretch is at 2075 cm
−1
with the symmetric CD2 stretch at 2100 cm
−1. The LC (A) monolayer SFG signal
disappeared indicating a collapse of the lipid monolayer. In the LC+LE (B) mono-
layer the small CD2 peak shows an intact monolayer. These spectra exhibit the
difference the initial monolayers have on AuNP–lipid interactions.
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nmAuNPs to the 20 nmAuNPs (Figures 3 and 4). In the LC
monolayer, there are changes in the CD vibrational modes
(CD3 and CD2) (Figure 4A) after the 20 nm NPs have been
injected. Indicating that the lipid monolayer’s packing has
an impact on the response to larger AuNPs. Shown in the
LC monolayer where the lipids are packed tightly enough
to resist the 20 nm NP from “snorkeling” into the
monolayer. The interaction between the 20 nm NP and
the lipid monolayer is kept intact, evident from the remain-
ing CD signal (Figure 4B). This binding induces
a curvature of the monolayer while holding together the
structure of the monolayer. The idea of a lipid monolayer
curving around a NP is supported by an atomistic simula-
tion where a negatively charged NP, absent of any coating,
induces curvature of a DPPC membrane through gains in
electrostatic energy at the loss of elastic energy.99 The
integrity of the lipid monolayer when interacting with 20
nm AuNPs is dependent on the initial degree of packing in
the monolayer. With the LC+LE monolayer, there was
a lack of signal and no distinguishable vibrational modes
in the CD region after 20 nm NP injection. This shows that
the 20 nm AuNPs have broken the non-centrosymmetric
environment leading to a disordering effect on the lipids. In
the LC+LE monolayer the lipids are more loosely packed
and the 20 nm AuNP is now able to “snorkel” into the
monolayer but causes a significant enough disruption to
disorder the lipids at the interface. Consistent with the lack
of SFG signal observed in (Figure 4A), this is in contrast to
“snorkel” behavior with the 5 and 10 nm AuNPs.
Toxicity Studies
In vivo Embryonic Zebrafish Toxicity
Embryonic zebrafish were exposed individually to each of
the AuNPs at concentrations ranging from 2.5 mg/L to
50 mg/L. Mortality is observed at both 24 hpf (Figure 7A)
and at 120 hpf (Figure 7B). Significant mortality is observed
in zebrafish exposed to the 5 nm AuNPs at concentrations
higher than 20 mg/L starting at 24 hpf. Due to the rapid
development of the zebrafish during the first 24 h window,
the trends in mortality become less clear at concentrations
greater than 20 mg/L. The variations in individual embryo
development during this window account for the large error
bars in their mortality response. A similar mortality trend
was observed at 120 hpf, with significant 120 hpf mortality
observed in the zebrafish exposed to concentrations of
20 mg/L or greater of the 5 nm AuNPs. No significant
mortality is observed in either the 10 nm or 20 nm AuNPs
at either of the 24 hpf or the 120 hpf time points.
Aside from mortality, three significant sublethal malfor-
mations are observed at 24 hpf. Malformations in the noto-
chord delayed developmental progression and impacts on
spontaneous movement may be predictive of teratogenic
outcomes at 120 hpf.100 Significant sublethal malforma-
tions are observed at 24 hpf in the 5 nm and 10 nm
AuNPs (Figure 8A and B). No significant malformations
Figure 5 SFG spectra showing the CH region for each of the 5, 10, 20 nm Au-SOA
-HPC-HT. The NPs are at an air/water interface free of any lipids. The CH2
asymmetric stretch is at 2913 cm−1 with the CH3 asymmetric stretch at
2963 cm−1. The NPs exhibit only asymmetric stretches which indicates strong
ordering of the lipid coating.
Figure 6 Representative SFG spectra showing the CH region for the lipid mono-
layer, 20 nm Au-SOA-HPC-HTand the NP-dDPPC lipid interface. The black squares
correspond to only the lipid monolayer at the air/water interface. The red triangles
correspond to only the Au-SOA-HPC-HT. The blue circles correspond to the
interaction of NPs and the lipid monolayer at the surface after 4 hrs. The CH2
asymmetric stretch is at 2913 cm−1 with the CH3 asymmetric stretch at 2963 cm
−1.
The spectra show that NPs are at the NP-dDPPC interface and responsible for the
observed structural changes in the lipid monolayer.
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are observed in the zebrafish exposed to the 20 nm AuNPs
(Figure 8C). There are no significant sublethal endpoints
observed at 120 hpf, only mortality.
The significant mortality and morbidity observed at 24
hpf in the embryonic zebrafish exposed to the 5 nm AuNPs
further substantiates the rapid insertion and uptake of the
Au-SOA-HPC-HT due to minimal-free energy cost. This
minimal-free energy cost is believed to allow for rapid
uptake into cells and may contribute to the increased
toxicity observed. The 10 nm AuNPs elicited moderate
morbidity at 24 hpf and no mortality at 120 hpf indicating
some uptake and minor developmental effects. The largest,
20 nm AuNPs, elicited no mortality or morbidity at 24 hpf
or 120 hpf, indicating very little uptake of the particles.
Others have showed similar size-dependent toxicity pat-
terns of AuNPs.23–25
We believe that when coated with a lipid bilayer, smaller
AuNPs with high radius of curvature will phase through cell
membranes, whereas larger (>10 nm) AuNPs with low radius
of curvature have to be endocytosed into cells. This is
demonstrated through the differential ordering and interac-
tions of the dPPC lipids with the AuNPs at the air–water
interface, imaged in vitro in human kidney cells, and shown
in vivo in embryonic zebrafish toxicity tests. These findings
and proposed mechanism of action are consistent with
simulations94 and studies of other NPs,101 leading to the belief
that this is a viable mechanism of uptake and toxicity. It would
be beneficial to further assess the size-dependent interactions
of AuNPs by utilizing larger and smaller particles tested to
further confirm the proposed mechanism.
Figure 7 Concentration–response curves of zebrafish mortality at (A) 24 hpf and
(B) 120 hpf. This data represents two experimental replicates of n = 12 for a total
of n = 24 for each exposure condition. *Indicates significant difference from control
by a Fisher’s exact test (p-value < 0.05).
Figure 8 Malformations assessed at 24 hpf show delayed developmental progres-
sion, notochord malformations, and effects on spontaneous movement in the
zebrafish exposed to the (A) 5 nm, (B) 10 nm, and (C) 20 nm AuNPs. This data
represents two experimental replicates of n = 12 for a total of n = 24 for each
exposure condition. *Indicates significant difference from control by a Fisher’s exact
test (p-value < 0.05).
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Conclusion
The size-dependent behavior of AuNPs is well under-
stood in the literature. AuNPs of varying sizes display
greatly different biouptake, biodistribution, excretion,
and ultimately toxicity. Many mechanisms of cellular
uptake, toxicity, and membrane interaction have been
proposed independently, but never investigated system-
atically together. Here, the size-dependent interactions of
AuNPs were assessed using a suite of NPs with well-
controlled surface coatings and sizes across various levels
of biological complexity. AuNP interactions with
a biomimetic lipid monolayer measured using SFG high-
lighted the size-dependent nature of the NPs. The SFG
measurements showed that the 5 nm and 10 nm AuNPs
with high radius of curvature are able to phase into the
membrane (Figure 9A), due to low energetic cost to do
so, whereas the largest, 20 nm AuNP, induced curvature
of the lipid monolayer (Figure 9B). In vitro, human
embryonic kidney cells exposed to AuNPs showed no
significant difference in viability across any concentra-
tions tested. TEM imaging confirmed no interaction or
uptake of the AuNPs into the cells, potentially due to the
lipid-bilayer surface coating on the AuNPs preventing
interaction with this specific cell type. In vivo, the rapid
uptake of the 5 nm AuNPs confirms that these NPs inflict
significant mortality and morbidity at 24 hpf in embryo-
nic zebrafish. The 20 nm AuNPs showed no significant
mortality or morbidity at 24 hpf nor at 120 hpf, confirm-
ing their less energetically favorable, slower uptake into
cells. Intermediate to both the 5 nm and 20 nm AuNPs the
10 nm AuNPs showed moderate morbidity at 24 hpf but
no mortality or morbidity at 120 hpf. Assessing the size-
dependent nature of AuNPs at three different levels of
biological complexity gives much greater insight into the
interactions and mechanisms that may be driving their
toxicity.
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